Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus (Q39230088)

10 September 2017

Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus (English)

1 reference

10 September 2017

1 reference

1 reference

8

Christof von Kalle

0 references

author name string

Johanna K Kaufmann

1

1 reference

10 September 2017

Sascha Bossow

2

1 reference

10 September 2017

Christian Grossardt

3

1 reference

10 September 2017

Stefanie Sawall

4

1 reference

10 September 2017

Jörg Kupsch

5

1 reference

10 September 2017

Philippe Erbs

6

1 reference

10 September 2017

Jessica C Hassel

7

1 reference

10 September 2017

Alexander H Enk

9

1 reference

10 September 2017

Dirk M Nettelbeck

10

1 reference

10 September 2017

Guy Ungerechts

11

1 reference

10 September 2017

language of work or name

English

0 references

publication date

6 December 2012

1 reference

Journal of Investigative Dermatology

10 September 2017

1 reference

10 September 2017

133

1 reference

10 September 2017

4

1 reference

10 September 2017

1034-1042

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2012.459

10 September 2017

0 references

cites work

New perspectives in cancer virotherapy: bringing the immune system into play

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Ipilimumab: first global approval

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Functional and clinical relevance of chondroitin sulfate proteoglycan 4.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Therapeutic potential of oncolytic measles virus: promises and challenges

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Epidemiology of invasive cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

RNA polymerase II-controlled expression of antigenomic RNA enhances the rescue efficacies of two different members of the Mononegavirales independently of the site of viral genome replication

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Rescue and propagation of fully retargeted oncolytic measles viruses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Antibody-targeted cell fusion

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single‐chain diabody (scDb) adapter that binds to fiber knob and HMWMAA

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Suicide genes for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Oncolytic virotherapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

An immunocompetent murine model for oncolysis with an armed and targeted measles virus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Preclinical testing of virotherapeutics for primary and secondary tumors of the liver

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.459

7 January 2021

Identifiers

DOI

10.1038/JID.2012.459

1 reference

10 September 2017

1 reference